Cholinergic nicotinic receptor involvement in movement disorders associated with Lewy body diseases. An autoradiography study using [(125)I]alpha-conotoxinMII in the striatum and thalamus.
about
Striatal cholinergic interneuron regulation and circuit effectsMolecular imaging biomarkers for dementia with Lewy bodies: an update.α6β2* and α4β2* nicotinic acetylcholine receptors as drug targets for Parkinson's disease.α-Conotoxin BuIA[T5A;P6O]: a novel ligand that discriminates between α6ß4 and α6ß2 nicotinic acetylcholine receptors and blocks nicotine-stimulated norepinephrine release.Nicotine and Parkinson's disease: implications for therapy.Role of α6 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disorders.Nicotinic receptors as CNS targets for Parkinson's diseasePresynaptic nicotinic receptors: a dynamic and diverse cholinergic filter of striatal dopamine neurotransmissionPositional scanning mutagenesis of α-conotoxin PeIA identifies critical residues that confer potency and selectivity for α6/α3β2β3 and α3β2 nicotinic acetylcholine receptors.Mysterious alpha6-containing nAChRs: function, pharmacology, and pathophysiology.Targeting nicotinic receptors for Parkinson's disease therapy.Enhancement of nicotinic receptors alleviates cytotoxicity in neurological disease models.Decrease of nicotinic receptors in the nigrostriatal system in Parkinson's disease.
P2860
Q26863113-56D3A5D0-0C55-48A7-B8BF-3F6790EA0CD9Q30881333-9A61B8B8-B385-456C-80C2-BA510CF26726Q35264378-C406EC4D-80B3-4B3A-ACED-83582E302D56Q35588867-215123B3-52CC-4595-A5ED-72F0AF4A7F56Q35601652-E8A9718F-E3BE-4F6A-B320-DE9D8D980612Q35690145-2CDC2EA5-C5FB-4E7B-990C-9A601855276AQ36882136-AA37CE78-5DCD-403D-A1FF-05F52038A63BQ37014100-32E29AE9-2F43-41F2-9E26-75366B3F76A4Q37132142-C57514D7-4463-435F-B80A-308336BAAC33Q37508589-36500D6B-7D44-4E9F-972C-B3B06F5D3A3AQ37916643-6B14BCEC-29A0-4B35-939B-2EE336334317Q38068415-5CF2EC53-B889-40AB-BD58-360D105CDAA9Q45985006-677F732C-BC96-4225-8349-E02B432BB08F
P2860
Cholinergic nicotinic receptor involvement in movement disorders associated with Lewy body diseases. An autoradiography study using [(125)I]alpha-conotoxinMII in the striatum and thalamus.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Cholinergic nicotinic receptor ...... autoradiography study using [
@nl
Cholinergic nicotinic receptor ...... in the striatum and thalamus.
@en
type
label
Cholinergic nicotinic receptor ...... autoradiography study using [
@nl
Cholinergic nicotinic receptor ...... in the striatum and thalamus.
@en
prefLabel
Cholinergic nicotinic receptor ...... autoradiography study using [
@nl
Cholinergic nicotinic receptor ...... in the striatum and thalamus.
@en
P2093
P50
P1476
Cholinergic nicotinic receptor ...... I in the striatum and thalamus
@en
P2093
F Clementi
J M McIntosh
M A Piggott
P304
P356
10.1016/J.EXPNEUROL.2004.10.004
P407
P577
2005-02-01T00:00:00Z